CS331091A3 - Synergistic combination of compounds inhibiting hiv-reverse transcriptase and a pharmaceutical based thereon - Google Patents

Synergistic combination of compounds inhibiting hiv-reverse transcriptase and a pharmaceutical based thereon Download PDF

Info

Publication number
CS331091A3
CS331091A3 CS913310A CS331091A CS331091A3 CS 331091 A3 CS331091 A3 CS 331091A3 CS 913310 A CS913310 A CS 913310A CS 331091 A CS331091 A CS 331091A CS 331091 A3 CS331091 A3 CS 331091A3
Authority
CS
Czechoslovakia
Prior art keywords
methyl
ethyl
pyridinone
amino
compound
Prior art date
Application number
CS913310A
Other languages
Czech (cs)
English (en)
Inventor
Paul A Friedman
Emilio A Emini
Jack Nunberg
Julio C Quintero
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CS331091A3 publication Critical patent/CS331091A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS913310A 1990-11-01 1991-10-31 Synergistic combination of compounds inhibiting hiv-reverse transcriptase and a pharmaceutical based thereon CS331091A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60810490A 1990-11-01 1990-11-01
US64585791A 1991-01-25 1991-01-25

Publications (1)

Publication Number Publication Date
CS331091A3 true CS331091A3 (en) 1992-05-13

Family

ID=27085675

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913310A CS331091A3 (en) 1990-11-01 1991-10-31 Synergistic combination of compounds inhibiting hiv-reverse transcriptase and a pharmaceutical based thereon

Country Status (15)

Country Link
EP (1) EP0484071A3 (fr)
JP (1) JPH04300834A (fr)
KR (1) KR920009394A (fr)
CN (1) CN1062138A (fr)
AU (1) AU648121B2 (fr)
CA (1) CA2054529A1 (fr)
CS (1) CS331091A3 (fr)
FI (1) FI915152L (fr)
HU (1) HUT60135A (fr)
IE (1) IE913751A1 (fr)
IL (1) IL99843A0 (fr)
MX (1) MX9101880A (fr)
NZ (1) NZ240407A (fr)
PT (1) PT99394A (fr)
YU (1) YU172991A (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
GB9215176D0 (en) * 1992-07-16 1992-08-26 Glaxo Group Ltd Antiviral combinations
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
SG49651A1 (en) * 1993-02-22 1998-06-15 Janssen Pharmaceutica Nv Method of reversing resistance of hiv-1 strains to zidovudine
RO118000B1 (ro) * 1993-03-31 2002-12-30 Merck & Co Inc Metoda pentru tratamentul sida, prevenirea si tratamentul infectiei cu hiv sau inhibarea proteazei hiv si compozitie farmaceutica pentru aplicarea metodei
US5968910A (en) * 1994-11-30 1999-10-19 Jan M. R. Balzarini Compositions containing two or three inhibitors of different HIV reverse transcriptases
WO1997037657A1 (fr) * 1996-04-04 1997-10-16 Shionogi & Co., Ltd. Composition anti-vih contenant un derive d'imidazole
RU2188638C2 (ru) * 1996-04-04 2002-09-10 Шионоги Энд Ко., Лтд. Анти-вич-композиция, содержащая имидазольные производные
US6469006B1 (en) * 1999-06-15 2002-10-22 Bristol-Myers Squibb Company Antiviral indoleoxoacetyl piperazine derivatives
NL1012825C2 (nl) * 1999-08-13 2001-02-23 Faculteit Geneeskunde Universi Farmaceuticum voor de behandeling van virale infecties in het bijzonder van het humane immunodeficiency virus (HIV).
US6476034B2 (en) 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US6573262B2 (en) 2000-07-10 2003-06-03 Bristol-Myers Sqibb Company Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
US20030207910A1 (en) 2001-02-02 2003-11-06 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20060100432A1 (en) 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7851476B2 (en) 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
GB0720503D0 (en) 2007-10-22 2007-11-28 Angeletti P Ist Richerche Bio New compound
WO2012019003A1 (fr) 2010-08-06 2012-02-09 Bristol-Myers Squibb Company Dérivés d'oxoacétyl pipérazinamide à substitution indole et azaindole
ES2585396T3 (es) 2010-12-02 2016-10-05 VIIV Healthcare UK (No.5) Limited Alquilamidas como inhibidores de la unión del VIH
WO2012142080A1 (fr) 2011-04-12 2012-10-18 Bristol-Myers Squibb Company Dérivés de thioamide, d'amidoxine et d'amidrazone comme inhibiteurs de l'attachement du vih
US8664213B2 (en) 2011-08-29 2014-03-04 Bristol-Myers Squibb Company Spiro bicyclic diamine derivatives as HIV attachment inhibitors
WO2013033061A1 (fr) 2011-08-29 2013-03-07 Bristol-Myers Squibb Company Dérivés fusionnés de diamine bicyclique utilisés en tant qu'inhibiteurs de la fixation du vih
WO2013138436A1 (fr) 2012-03-14 2013-09-19 Bristol-Myers Squibb Company Dérivés d'hydrazine cycliques en tant qu'inhibiteurs de fixation du vih
CN108299428B (zh) * 2018-04-04 2019-09-27 山东大学 8-胺基-7-甲酸甲酯-吡嗪骈吡啶酮衍生物及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU641769B2 (en) * 1990-06-18 1993-09-30 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase

Also Published As

Publication number Publication date
CN1062138A (zh) 1992-06-24
EP0484071A3 (en) 1992-11-25
AU8693491A (en) 1992-05-07
HU913435D0 (en) 1992-01-28
KR920009394A (ko) 1992-06-25
YU172991A (sh) 1994-06-24
FI915152A0 (fi) 1991-10-31
NZ240407A (en) 1994-09-27
FI915152A7 (fi) 1992-05-02
JPH04300834A (ja) 1992-10-23
CA2054529A1 (fr) 1992-05-02
MX9101880A (es) 1992-07-08
IE913751A1 (en) 1992-05-22
FI915152L (fi) 1992-05-02
IL99843A0 (en) 1992-08-18
AU648121B2 (en) 1994-04-14
PT99394A (pt) 1992-09-30
HUT60135A (en) 1992-08-28
EP0484071A2 (fr) 1992-05-06

Similar Documents

Publication Publication Date Title
CS331091A3 (en) Synergistic combination of compounds inhibiting hiv-reverse transcriptase and a pharmaceutical based thereon
US5583131A (en) Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity
EP3409276B1 (fr) Inhibiteurs d'ire-1a
US5308854A (en) Inhibitors of HIV reverse transcriptase
CZ280532B6 (cs) Pyridinové a pyridin-N-oxidové deriváty diaryl-methyl-piperidinů nebo piperazinů, jejich použití a způsob jejich přípravy, farmaceutický prostředek je obsahující
CZ400892A3 (en) 2-(4-hydroxypiperidino)-1-alkanol derivatives as anti-ischemic agents, process of their preparation and use
JP5404607B2 (ja) 抗ｒｎａウイルス作用を有するアニリン誘導体
JPH01265100A (ja) ２―置換アデノシン誘導体
CN101463014A (zh) 二芳基苯并嘧啶类衍生物及其制备方法和用途
JP2002519413A (ja) ヒト免疫不全ウイルスの複製を阻害するピペラジン誘導体
JP2000508299A (ja) 抗ウイルス作用を有する置換キノリン誘導体
NO327549B1 (no) Benzo[G]kinolinderivater for behandling av glaukom og myopi
WO2014012467A1 (fr) Composé diarylaniline ou diarylpyridinamine et son procédé de préparation et son utilisation médicale
EP0843663B9 (fr) 4-aryl-thio-pyridin-2(1h)-ones, medicaments les contenant et leurs utilisations dans le traitement de maladies liees aux vih
JPH0375542B2 (fr)
Irikura et al. New antiulcer agents. 1. Synthesis and biological activities of 1-acyl-2-,-3-, and-4-substituted benzamidopiperidines
JPH0377191B2 (fr)
Rostom et al. Synthesis and in vitro anti-HIV screening of certain 2-(benzoxazol-2-ylamino)-3H-4-oxopyrimidines
EP0462808A2 (fr) Inhibiteurs de transcriptase inverse de HIV
JPH06234753A (ja) イソオキサゾール化合物およびその塩
JP3709203B2 (ja) ５−ｈｔ１ａレセプターに対して親和性をもつ三環式化合物
KR100824831B1 (ko) 다치환된 1,1-피리딜아미노시클로프로판아민 화합물, 이의제조 방법, 및 이를 함유하는 약제 조성물
JPS625968A (ja) 新規ｎ置換３，４―ジヒドロピリミジン誘導体および血管拡張剤
JPH0770083A (ja) イミダゾール誘導体を有効成分とする血圧降下剤
WO2014012466A1 (fr) Composés de diarylanilines et de diarylpyridinamines, leur procédé de préparation et leurs utilisations